[Ip-health] Company’s attempt to switch its patients to a new drug is foiled

Ruth Lopert ruth.lopert at gmail.com
Tue Dec 23 20:15:36 PST 2014


BMJ 2014; 349 doi: http://dx.doi.org/10.1136/bmj.g7802



More information about the Ip-health mailing list